" #Adicet believes it may be able to sidestep [ #SideEffects ] with a diff kind of #treatment. Its therapy “prula-cel” is derived from the #cells of donors, an “allogeneic” approach that’s quicker & less costly to manufacture.": buff.ly/U0s5mT3

via @biopharmadive.com
#lupus #ClinicalTrial #CARTCell